Patient radiation dose associated with uterine artery embolization

Boris Nikolic, James B. Spies, Michael J. Lundsten, Suhny Abbara

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

PURPOSE: To evaluate the estimated absorbed radiation doses to the ovaries and skin entrance during uterine artery embolization (UAE) for leiomyomas. MATERIALS AND METHODS: Radiation dose was measured in 20 patients who underwent UAE for leiomyomas. Measurements were obtained by placing lithium fluoride dosimeters both into the posterior fornix of the vagina and on the skin at the beam entrance site. Patient doses were obtained with thermoluminescent dosimeters. RESULTS: The mean fluoroscopic time was 21.89 minutes, and the mean number of angiographic exposures was 44. The mean estimated absorbed ovarian dose was 22.34 cGy, and the mean absorbed skin dose was 162.32 cGy. These values compare to published values for the assessed absorbed ovarian dose during hysterosalpingography (0.04-0.55 cGy), fallopian tube recanalization (0.2-2.75 cGy), computed tomography of the trunk (0.1-1.9 cGy), and pelvic irradiation for Hodgkin disease (263-3,500 cGy). CONCLUSION: The estimated absorbed ovarian dose during UAE is greater than that during common fluoroscopic procedures. On the basis of the known risks of pelvic irradiation for Hodgkin disease, the dose associated with UAE is unlikely to result in acute or long-term radiation injury to the patient or to a measurable increase in the genetic risk to the patient's future children.

Original languageEnglish (US)
Pages (from-to)121-125
Number of pages5
JournalRadiology
Volume214
Issue number1
StatePublished - 2000

Fingerprint

Uterine Artery Embolization
Radiation
Leiomyoma
Hodgkin Disease
Skin
Hysterosalpingography
Radiation Injuries
Fallopian Tubes
Vagina
Ovary
Tomography
Radiation Dosimeters

Keywords

  • Interventional procedures, technology
  • Ovary
  • Radiations, exposure to patients and personnel
  • Radiations, injurious effects
  • Uterine neoplasms, therapy

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Nikolic, B., Spies, J. B., Lundsten, M. J., & Abbara, S. (2000). Patient radiation dose associated with uterine artery embolization. Radiology, 214(1), 121-125.

Patient radiation dose associated with uterine artery embolization. / Nikolic, Boris; Spies, James B.; Lundsten, Michael J.; Abbara, Suhny.

In: Radiology, Vol. 214, No. 1, 2000, p. 121-125.

Research output: Contribution to journalArticle

Nikolic, B, Spies, JB, Lundsten, MJ & Abbara, S 2000, 'Patient radiation dose associated with uterine artery embolization', Radiology, vol. 214, no. 1, pp. 121-125.
Nikolic B, Spies JB, Lundsten MJ, Abbara S. Patient radiation dose associated with uterine artery embolization. Radiology. 2000;214(1):121-125.
Nikolic, Boris ; Spies, James B. ; Lundsten, Michael J. ; Abbara, Suhny. / Patient radiation dose associated with uterine artery embolization. In: Radiology. 2000 ; Vol. 214, No. 1. pp. 121-125.
@article{8e27bea3189d4974b49fa303aba04c43,
title = "Patient radiation dose associated with uterine artery embolization",
abstract = "PURPOSE: To evaluate the estimated absorbed radiation doses to the ovaries and skin entrance during uterine artery embolization (UAE) for leiomyomas. MATERIALS AND METHODS: Radiation dose was measured in 20 patients who underwent UAE for leiomyomas. Measurements were obtained by placing lithium fluoride dosimeters both into the posterior fornix of the vagina and on the skin at the beam entrance site. Patient doses were obtained with thermoluminescent dosimeters. RESULTS: The mean fluoroscopic time was 21.89 minutes, and the mean number of angiographic exposures was 44. The mean estimated absorbed ovarian dose was 22.34 cGy, and the mean absorbed skin dose was 162.32 cGy. These values compare to published values for the assessed absorbed ovarian dose during hysterosalpingography (0.04-0.55 cGy), fallopian tube recanalization (0.2-2.75 cGy), computed tomography of the trunk (0.1-1.9 cGy), and pelvic irradiation for Hodgkin disease (263-3,500 cGy). CONCLUSION: The estimated absorbed ovarian dose during UAE is greater than that during common fluoroscopic procedures. On the basis of the known risks of pelvic irradiation for Hodgkin disease, the dose associated with UAE is unlikely to result in acute or long-term radiation injury to the patient or to a measurable increase in the genetic risk to the patient's future children.",
keywords = "Interventional procedures, technology, Ovary, Radiations, exposure to patients and personnel, Radiations, injurious effects, Uterine neoplasms, therapy",
author = "Boris Nikolic and Spies, {James B.} and Lundsten, {Michael J.} and Suhny Abbara",
year = "2000",
language = "English (US)",
volume = "214",
pages = "121--125",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Patient radiation dose associated with uterine artery embolization

AU - Nikolic, Boris

AU - Spies, James B.

AU - Lundsten, Michael J.

AU - Abbara, Suhny

PY - 2000

Y1 - 2000

N2 - PURPOSE: To evaluate the estimated absorbed radiation doses to the ovaries and skin entrance during uterine artery embolization (UAE) for leiomyomas. MATERIALS AND METHODS: Radiation dose was measured in 20 patients who underwent UAE for leiomyomas. Measurements were obtained by placing lithium fluoride dosimeters both into the posterior fornix of the vagina and on the skin at the beam entrance site. Patient doses were obtained with thermoluminescent dosimeters. RESULTS: The mean fluoroscopic time was 21.89 minutes, and the mean number of angiographic exposures was 44. The mean estimated absorbed ovarian dose was 22.34 cGy, and the mean absorbed skin dose was 162.32 cGy. These values compare to published values for the assessed absorbed ovarian dose during hysterosalpingography (0.04-0.55 cGy), fallopian tube recanalization (0.2-2.75 cGy), computed tomography of the trunk (0.1-1.9 cGy), and pelvic irradiation for Hodgkin disease (263-3,500 cGy). CONCLUSION: The estimated absorbed ovarian dose during UAE is greater than that during common fluoroscopic procedures. On the basis of the known risks of pelvic irradiation for Hodgkin disease, the dose associated with UAE is unlikely to result in acute or long-term radiation injury to the patient or to a measurable increase in the genetic risk to the patient's future children.

AB - PURPOSE: To evaluate the estimated absorbed radiation doses to the ovaries and skin entrance during uterine artery embolization (UAE) for leiomyomas. MATERIALS AND METHODS: Radiation dose was measured in 20 patients who underwent UAE for leiomyomas. Measurements were obtained by placing lithium fluoride dosimeters both into the posterior fornix of the vagina and on the skin at the beam entrance site. Patient doses were obtained with thermoluminescent dosimeters. RESULTS: The mean fluoroscopic time was 21.89 minutes, and the mean number of angiographic exposures was 44. The mean estimated absorbed ovarian dose was 22.34 cGy, and the mean absorbed skin dose was 162.32 cGy. These values compare to published values for the assessed absorbed ovarian dose during hysterosalpingography (0.04-0.55 cGy), fallopian tube recanalization (0.2-2.75 cGy), computed tomography of the trunk (0.1-1.9 cGy), and pelvic irradiation for Hodgkin disease (263-3,500 cGy). CONCLUSION: The estimated absorbed ovarian dose during UAE is greater than that during common fluoroscopic procedures. On the basis of the known risks of pelvic irradiation for Hodgkin disease, the dose associated with UAE is unlikely to result in acute or long-term radiation injury to the patient or to a measurable increase in the genetic risk to the patient's future children.

KW - Interventional procedures, technology

KW - Ovary

KW - Radiations, exposure to patients and personnel

KW - Radiations, injurious effects

KW - Uterine neoplasms, therapy

UR - http://www.scopus.com/inward/record.url?scp=0033962339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033962339&partnerID=8YFLogxK

M3 - Article

C2 - 10644110

AN - SCOPUS:0033962339

VL - 214

SP - 121

EP - 125

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -